Charlie's Holdings (OTCQB:CHUC) to Present at Dawson James Small Cap Growth Conference and LD Micro Main Event

Rhea-AI Summary

Charlie's Holdings, Inc. (OTCQB:CHUC) is set to achieve its best year ever in 2022, according to President Henry Sicignano III. The company will participate in two major investor conferences: the Dawson James Securities Small Cap Growth Conference on October 12, 2022, and the LD Micro Main Event on October 25, 2022. Sicignano highlighted the ongoing FDA reviews of their e-liquids and impressive growth in their nicotine-based vapor products and cannabis product categories. Investors can arrange one-on-one meetings at both events.

"Charlie's is on a trajectory to achieve the best year in Company history."

COSTA MESA, CA / ACCESSWIRE / October 5, 2022 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium, nicotine-based, vapor products space, today announced that the Company will participate in the following investor conferences during the month of October 2022:

• On Wednesday, October 12, 2022, the Company will host investor meetings at the 7^th annual Dawson James Securities Small Cap Growth Conference at the Wyndham Grand Hotel in Jupiter, Florida. To register for the conference and to request a meeting, please click this link Dawson James Small Cap Growth Conference.
• On Tuesday, October 25, 2022, at 2:30 p.m. ET, the Company will make a presentation to investors at the LD Micro Main Event conference at the Luxe Sunset Boulevard Hotel in Santa Monica, California. The Company will also host investor meetings. To register for the conference and to request a meeting, please click this link http://www.ldmicro.com.

Henry Sicignano III, Charlie's President, commented, "I am proud to report: Charlie's best-selling e-liquids remain in ‘substantive review' with the FDA and stand among the select minority of 2020 PMTA submissions to the FDA that are still viable. The Company's nicotine-based vapor product lines are growing impressively. What's more, the Company's alternative cannabis product category, which includes Delta-8 and other hemp-derived THC compounds, is experiencing unprecedented growth. Indeed, Charlie's is on a trajectory to achieve the best year in Company history… we are very excited for what lies ahead!"

Investors, and others who are invited to attend the Dawson James and LD Micro conferences, may request one-on-one meetings through the respective conference hosts or by contacting the Charlie's Holdings investor relations team via IR@charliesholdings.com.

About Charlie's Holdings, Inc.

Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium, nicotine-based, vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary companies Charlie's Chalk Dust, LLC and Don Polly, LLC. Charlie's Chalk Dust, LLC has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats. Don Polly, LLC creates innovative hemp-derived products and brands.

For additional information, please visit Charlie's corporate website at: Chuc.com and the Company's branded online websites: CharliesChalkDust.com, Pacha.co, and Pinweel.com.

About Dawson James Securities

Dawson James Securities, Inc., a member of FINRA/SIPC, is a full-service investment bank headquartered in Boca Raton, FL. http://www.dawsonjames.com.

About LD Micro (NASDAQ:SRAX)

LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD's sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.http://www.ldmicro.com

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to uplist to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's will be granted marketing orders by the FDA, and the FDA's decisions with respect to the Company's future PMTA submissions; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations, including recent regulation of synthetic nicotine; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

Investors Contact:
IR@charliesholdings.com
Phone: 949-570-0691

SOURCE: Charlie's Holdings, Inc.

View source version on accesswire.com:
https://www.accesswire.com/718949/Charlies-Holdings-OTCQBCHUC-to-Present-at-Dawson-James-Small-Cap-Growth-Conference-and-LD-Micro-Main-Event

FAQ

When is Charlie's Holdings presenting at the Dawson James Securities Small Cap Growth Conference?

Charlie's Holdings will host investor meetings at the Dawson James Securities Small Cap Growth Conference on October 12, 2022.

What is the date and time of Charlie's Holdings presentation at the LD Micro Main Event?

Charlie's Holdings will present on October 25, 2022, at 2:30 p.m. ET at the LD Micro Main Event.

What is the significance of FDA review for Charlie's Holdings e-liquids?

Charlie's best-selling e-liquids are in 'substantive review' by the FDA, a crucial step for their viability.

How is Charlie's Holdings performing in the cannabis product market?

Charlie's Holdings reports unprecedented growth in its alternative cannabis product category, including Delta-8 and hemp-derived THC.

What should investors know about meetings with Charlie's Holdings during the conferences?

Investors interested in one-on-one meetings can request them through the conference hosts or by contacting Charlie's investor relations at IR@charliesholdings.com.